Since ERα expression is essential for anti-estrogen therapy, it will be of great importance to investigate the mechanisms of ERα loss or reduction in breast cancer cells and explore effective interventions to restore ERα expression in those malignancies. Here, ESR1 is linked to breast carcinoma.